Economy & Business 2 Mins ReadAbCellera: Shares Have Momentum, However Does The Pipeline? It is Too Early To Inform (NASDAQ:ABCL)By Admin03/10/20252 Mins Read This text was written byObserveEdmund Ingham is a biotech marketing consultant. He has been protecting biotech, healthcare, and pharma for…
Economy & Business 2 Mins ReadAbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Name TranscriptBy Admin08/08/20252 Mins Read AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2025 Earnings Convention Name August 7, 2025 5:00 PM ET Firm Individuals Andrew Sales space…
